For the first time in over 25 years (since the approval of oxybutynin in 1972), better medications are available for the overactive bladder. With the recent approval of tolterodine and oxybutynin ...

Urodynamics investigation to identify detrusor overactivity before proceeding to invasive overactive bladder treatments do not appear helpful.

Overactive bladder is a well established and bothersome clinical condition for which antimuscarinic drugs are the treatment of choice. Oxybutynin, the longest established antimuscarinic, is a ...

Gemtesa is a brand-name oral tablet prescribed for overactive bladder (OAB). Gemtesa contains the active drug vibegron and belongs to the beta-3 adrenergic agonists drug class. Gemtesa is FDA ...

Life's Crucial 9 (LC9), a recently proposed method for assessing cardiovascular health, has a strong negative correlation with overactive bladder (OAB), which is partially mediated by the weight ...

Gemtesa (vibegron) is a brand-name drug prescribed for overactive bladder in adults. Gemtesa comes as an oral tablet that’s typically taken once per day. The dosage can vary based on your health ...